Open repair, endovascular repair, and conservative management of true splenic artery aneurysms
Hogendoorn W, Lavida A, Hunink MG, Moll FL, Geroulakos G, Muhs BE, Sumpio BE. Open repair, endovascular repair, and conservative management of true splenic artery aneurysms. Journal Of Vascular Surgery 2014, 60: 1667-1676.e1. PMID: 25264364, DOI: 10.1016/j.jvs.2014.08.067.Peer-Reviewed Original ResearchConceptsTrue splenic artery aneurysmsSplenic artery aneurysmLate mortality rateEndovascular repairConservative managementSystematic reviewPerioperative mortalityOpen repairArtery aneurysmMortality rateManagement of SAAHigher late mortality rateRuptured splenic artery aneurysmEV groupGood short-term resultsHigh perioperative mortalityLow perioperative mortalityNumber of reinterventionsMajor treatment modalityTreatment of choiceSmall-sized aneurysmsMeta-Analyses (PRISMA) guidelinesShort-term resultsPreferred Reporting ItemsCONS groupA comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model
Hogendoorn W, Hunink MG, Schlösser FJ, Moll FL, Muhs BE, Sumpio BE. A comparison of open and endovascular revascularization for chronic mesenteric ischemia in a clinical decision model. Journal Of Vascular Surgery 2014, 60: 715-725.e2. PMID: 24721175, DOI: 10.1016/j.jvs.2014.03.009.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsAgedAged, 80 and overComparative Effectiveness ResearchComputer SimulationCost-Benefit AnalysisDecision Support TechniquesEndovascular ProceduresFemaleHealth Care CostsHumansIschemiaMaleMarkov ChainsMesenteric IschemiaMiddle AgedPatient SelectionPredictive Value of TestsQuality of LifeQuality-Adjusted Life YearsReoperationRisk AssessmentRisk FactorsSex FactorsTime FactorsTreatment OutcomeVascular DiseasesVascular PatencyVascular Surgical ProceduresConceptsChronic mesenteric ischemiaIncremental cost-effectiveness ratioEndovascular revascularizationCost-effectiveness ratioMesenteric ischemiaFemale patientsMortality riskAge groupsGood short-term resultsDisease-specific mortality riskPatients 60 yearsOverall mortality riskMarkov state transition modelTreatment of choiceExpensive treatment strategiesShort-term resultsHealth care perspectiveHealth care costsDifferent clinical scenariosProbabilistic sensitivity analysesClinical decision modelDecision analysis modelOlder patientsConservative managementYounger patients